10.600
+1,92%
2026-10-19
Fundamental Analysis
37 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +3.6% | +7.0% | 2 / 3 | +5.8% | -1.81 pp | -0.27 pp | +9.5% | 0.37 | 8.52 | 4.053 | +5,8% | 331 | +2,4% | 8.52 | 11.36 | −25,0% |
| Pts | 0 | 0 | 8 | 0 | 4 | 4 | 0 | 12 | 12 | |||||||
Valuation annotation:Price: 10.600 (close price on 2026-10-19)EPS (TTM): 1.245
Financial charts
1.Revenue & growth
VND bn4.053Q2/26
1.Revenue & growth
VND bn4.053Q2/26
2.Profit & growth
VND bn334Q2/26
3.Profit mix (Penman)
VND bn1.020Q2/26
4.Margins & cost structure
%10.3%Q2/26
5.Returns & cash cycle
% · days7.1%Q2/26
6.Earnings quality & cash
VND bn1.660Q2/26
7.Asset structure
VND bn16.605Q2/26
8.Funding & debt health
VND bn · times16.605Q2/26
9.Revenue backlog
VND bn0,69Q2/26
10.Valuation
times · %8,5×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %490Q2/26
Adjusted EPS growth, latest quarter
3.6%
Average adjusted EPS growth, 3 quarters
7.0%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26